Ra Medical Systems Hosts Summit with Vascular Physicians to Monitor Progress on Next-Generation DABRA Catheter Design
Source: Business Wire
Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces a one-day DABRA Summit, during which participants will have the opportunity to provide input on the design features and enhancements for the Company’s next-generation DABRA catheters. Principal investigators and study coordinators from Ra Medical’s DABRA pivotal atherectomy clinical trial will also meet to share with one another insights on best practices.
“Convening this DABRA Summit with leaders in the field of vascular surgery, interventional radiology and interventional cardiology demonstrates our progress in engineering the next-generation DABRA catheter. This hands-on workshop will allow us to incorporate input on the usability and performance features we are building into our next-generation DABRA catheters,” said Will McGuire, Ra Medical Systems CEO. “We are highly focused on providing an enhanced product that exceeds their expectations.
“We also will be meeting with the clinical investigators for the atherectomy trial. With patient enrollment now open in five clinical sites, we will use this forum to share best practices in driving successful enrollment, patient outcomes and subject retention,” he added. “Making improvements and enhancements to our DABRA catheter along with advancing the atherectomy trial are our top priorities, and these meetings are expected to provide critical information to support our success.”
DABRA is Ra Medical’s excimer laser system used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease.
